GLAXOSMITH - Glaxo Smithkline Consumer
Manufacturing, Marketing and Distribution of Pharmaceutical, Oral Care and Nutritional Products
|Last Trading Results|
|Day’s Low Price||6.10|
|Day’s High Price||6.10|
|Number of Deals||31|
|Growth & Valuation|
|Earnings Per Share||0.58|
|Dividend Per Share|
GLAXOSMITH Stock Market Performance
The current share price of Glaxo Smithkline Consumer (GLAXOSMITH) is NGN 6.10. GLAXOSMITH closed its last trading day (Friday, September 24, 2021) at 6.10 NGN per share on the Nigerian Stock Exchange (NGX), recording a 1.7% gain over its previous closing price of 6.00 NGN. Glaxo Smithkline Consumer began the year with a share price of 6.90 NGN but has since lost 11.6% off that price valuation, ranking it 126th on the NGX in terms of year-to-date performance. Shareholders’ worries are compounded by the fact that GLAXOSMITH has lost 10% of the stock’s value from August 27th to date.
Glaxo Smithkline Consumer is the 72nd most traded stock on the Nigerian Stock Exchange over the past three months (Jun 28 - Sep 24, 2021). GLAXOSMITH has traded a total volume of 16.3 million shares—in 1,104 deals—valued at NGN 99.7 million over the period, with an average of 259,362 traded shares per session. A volume high of 2.01 million was achieved on September 21st, and a low of 1,955 on July 6th, for the same period. The table below details the last 10 trading days of activity of Glaxo Smithkline Consumer on the Nigerian Stock Exchange.
Profile of Glaxo Smithkline Consumer
Glaxo Smithkline Consumer operates in the Health Care sector.
|Factsheet of Glaxo Smithkline Consumer|
1, Industrial Avenue, Ilupeju Lagos
GLAXOSMITH Industrial Market Competitors
Glaxo Smithkline Consumer, issuers of the GLAXOSMITH stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care sector. The table below presents an overview of their market standing.
|MAYBAKER||May & Baker Nigeria||7.71B||4.47||+27.4%|
|NEIMETH||Neimeth International Pharma||3.32B||1.75||-21.5%|